Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body. Albumin is the major carrier molecule in the human body for […]
Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend today along with the appointment of Michael Feldschuh, currently Executive Vice President, as […]
Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed an unaudited Form N-Q on Tuesday, November 24th disclosing its schedule of portfolio holdings as of September 30, 2015.Copies of the form are available on the Company’s website at http://www.daxor.com/pdfs/Daxor_NQ_11_24_15.pdf. Daxor has been reporting as an investment company under the Investment Company Act […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.